SPONSOR
Gan & Lee Pharmaceuticals.
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 3
NCT07141030 Phase 1
Recruiting
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function
Obesity/Overweight
NCT06780410 Phase 3
Recruiting
A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
Primary Hyperlipidemia
NCT07292441 Phase 3
Recruiting
Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss
Overweight or Obesity
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology